Remove topics joinder
article thumbnail

PTAB Updates and Expands the Director Review Process and Offers Transparency in Ex parte Appeals

LexBlog IP

§ 315(c) permits a petitioner to be joined to an AIA trial proceeding in which it is already a party and permits joinder of new issues to an existing proceeding under certain circumstances. The memo includes a discussion of the following topics, among others: Instances where the Board will not decide all appealed issues.

article thumbnail

2021 Post-Grant Report

Fish & Richardson Trademark & Copyright Thoughts

Both Apotex and Celltrion moved for joinder with Mylan’s instituted petitions. Denials of institution – particularly the extent to which they are reviewable – have long been a contentious topic for the PTAB. and Celltrion, Inc. Institution Reviewability. Network-1 Techs v. Hewlett-Packard Co., 3d 1015 (Fed. Uniloc 2017 LLC v.

article thumbnail

Biosimilars 2021 Year in Review

Fish & Richardson Trademark & Copyright Thoughts

The letter discusses the BPCIA and the Hatch-Waxman Act frameworks (for small molecule drugs) and sets forth several topics for USPTO’s consideration and further discussion: engagement between FDA and USPTO to increase efficiencies, possible misuse of the patent system (e.g., The PTAB granted institution of both IPRs in November 2021.